Home > Journals > Minerva Endocrinology > Past Issues > Minerva Endocrinologica 2010 September;35(3) > Minerva Endocrinologica 2010 September;35(3):153-9

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

REVIEWS  MULTINODULAR GOITER 

Minerva Endocrinologica 2010 September;35(3):153-9

Copyright © 2010 EDIZIONI MINERVA MEDICA

language: English

Diagnostic imaging work up in multi-nodular goiter

Luster M. 1, Verburg F. A. 2, Scheidhauer K. 3

1 Department of Nuclear Medicine, University of Ulm, Ulm, Germany; 2 Department of Nuclear Medicine, University of Würzburg, Würzburg, Germany; 3 Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universität München,Munich, Germany


PDF


Ultrasound, scintigraphy and sonographically guided fine-needle biopsy are the cornerstones in the diagnostic work-up multinodular goitre. Subsequent decisions for adequate treatments should be based on accurate tests to avoid unnecessary intervention. Especially in areas with endemic goitre a preselection of patients for the most effective procedure e.g. surgical or medical treatment is mandatory. Autoimmune hyperthyroidism (Graves’ disease), solitary hyperfunctioning thyroid nodules and toxic multinodular goitre (Plummer’s disease) constitute a clear indication for radioiodine treatment in many cases. Recently, there is an emerging role for I-131 in the treatment for so called subclinical hyperthyroidism caused by either of three first entities and for patients with non-toxic goitre, in whom surgery is not an option. These patients with large non toxic goitre encompass a group of patients who are euthyroid but may benefit from diminishment of thyroid volume. We review the spectrum of diagnostic tests and provide some recommendations regarding (nuclear medicine) therapy.

top of page